Gene · 5452
Papers3,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Triterpenoids from Protorhus longifolia Exhibit Hypocholesterolemic Potential via Regulation of Cholesterol Biosynthesis and Stimulation of Low-Density Lipoprotein Uptake in HepG2 Cells. | ACS Omega | 2023 | 37663489 | PubTator, text mining | PubMed |
| The organization of spinal neurons: Insights from single cell sequencing. | Curr Opin Neurobiol | 2023 | 37657185 | PubTator, text mining | PubMed |
| E2F3 renders an immunosuppressive tumor microenvironment in nasopharyngeal carcinoma: Involvements of the transcription activation of PRC1 and BIRC5. | Immun Inflamm Dis | 2023 | 37647439 | PubTator, text mining | PubMed |
| Primary follicular lymphoma of an extraordinarily large prostate: A case report and review of the literature. | Urol Case Rep | 2023 | 37645680 | PubTator, text mining | PubMed |
| Structure-Based Multi-Targeted Molecular Docking and Dynamic Simulation of Soybean-Derived Isoflavone Genistin as a Potential Breast Cancer Signaling Proteins Inhibitor. | Life (Basel) | 2023 | 37629596 | PubTator, text mining | PubMed |
| Increased Bone Formation and Accelerated Bone Mass Accrual in a Man Presenting with Diffuse Osteosclerosis/High Bone Mass Phenotype and Adenocarcinoma of Unknown Primary. | JBMR Plus | 2023 | 37614304 | PubTator, text mining | PubMed |
| Digital pathology in pediatric nodular lymphocyte-predominant Hodgkin lymphoma: correlation with treatment response. | Blood Adv | 2023 | 37611165 | PubTator, text mining | PubMed |
| A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of ART-001 with a novel oral pediatric formulation in healthy subjects. | Clin Transl Sci | 2023 | 37606073 | PubTator, text mining | PubMed |
| POU6F2 mutation in humans with pubertal failure alters GnRH transcript expression. | Front Endocrinol (Lausanne) | 2023 | 37600690 | PubTator, text mining | PubMed |
| Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies. | Front Pharmacol | 2023 | 37593174 | PubTator, text mining | PubMed |
| Development and application of a PBPK modeling strategy to support antimalarial drug development. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37587640 | PubTator, text mining | PubMed |
| Correction: Reprogramming anchorage dependency by adherent‑to‑suspension transition promotes metastatic dissemination. | Mol Cancer | 2023 | 37580748 | PubTator, text mining | PubMed |
| Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and Pharmacoprofiling. | Int J Mol Sci | 2023 | 37569654 | PubTator, text mining | PubMed |
| A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data. | BMC Cancer | 2023 | 37568126 | PubTator, text mining | PubMed |
| Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms. | Leukemia | 2023 | 37563306 | PubTator, text mining | PubMed |
| Epstein-Barr virus evades restrictive host chromatin closure by subverting B cell activation and germinal center regulatory loci. | Cell Rep | 2023 | 37561629 | PubTator, text mining | PubMed |
| Single-Cell Sequencing in Neurodegenerative Disorders. | Mol Diagn Ther | 2023 | 37552451 | PubTator, text mining | PubMed |
| Cerebral manifestation and diagnostic dilemma of Rosai-Dorfman disease. | CNS Oncol | 2023 | 37551608 | PubTator, text mining | PubMed |
| BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes. | Mol Cancer | 2023 | 37543582 | PubTator, text mining | PubMed |
| TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. | PLoS One | 2023 | 37535601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5452/papers?page=15